GEST: Cognitive Embodiment Activation by tDCS

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Completed
CT.gov ID
NCT03094520
Collaborator
(none)
22
1
2
29
0.8

Study Details

Study Description

Brief Summary

The main objective of the proposed research is to extend our understanding of how gesture and language interact, focusing on the role of cognitive embodiment in this interaction, and to explore the neural systems that support links between language and actions systems.

Condition or Disease Intervention/Treatment Phase
  • Device: tDCS
  • Device: sham-tDCS
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effects of Transcranial Direct Current Stimulation (tDCS) on Gestural-verbal Brain Associations: the Role of Cognitive Embodiment
Actual Study Start Date :
May 1, 2016
Actual Primary Completion Date :
May 1, 2018
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anodal tDCS + semantic, motor, attentional tasks

Combination of gestural (subjects have to indicate if the gesture is related to the word), attentional and motor tasks with anodal stimulation

Device: tDCS
Transcranial direct current stimulation (tDCS)
Other Names:
  • Neuroconn
  • Sham Comparator: Sham tDCS + semantic, motor, attentional tasks

    Combination of gestural (subjects have to indicate if the gesture is related to the word), attentional and motor tasks with sham stimulation

    Device: sham-tDCS
    sham stimulation
    Other Names:
  • Neuroconn
  • Outcome Measures

    Primary Outcome Measures

    1. response time in semantic decision task [assessed during stimulation or sham stimulation of semantic decision task (last approximately 10 min) at specific timepoint within 2 weeks]

      Comparing response time in semantic decision task under anodal tDCS compared to sham stimulation (change from sham stimulation)

    2. performance in attentional load task [assessed during stimulation or sham stimulation of attentional load task (last approximately 6 min) at specific timepoint within 2 weeks]

      Attentional load task: Participants are presented with a 6 positions ring that includes different shapes, they have to press V when they see a square and N when they see a diamond. They will have to ignore any shapes other than square and diamond within the ring or distractors that appear outside the ring. Comparing performance in attentional load task under anodal tDCS compared to sham stimulation (change from sham stimulation)

    3. performance in motor task [assessed during stimulation or sham stimulation of motor task (last approximately 4 min) at specific timepoint within 2 weeks]

      Motor Task: Participants are presented with a red Box and they have to click a button each time they see it as fast as they can. Comparing performance in motor task under anodal tDCS compared to sham stimulation (change from sham stimulation)

    Secondary Outcome Measures

    1. Functional connectivity predictors [assessed during baseline testing]

      Connectivity as measured by resting-state fMRI during baseline as predictors for performance and tDCS responsiveness

    2. Other cognitive outcomes: change in working memory performance [change in working memory performance from baseline after 30 min (approximately)]

      Digit span backward performance assessed before (baseline) and after stimulation to test for tDCS effects on working memory

    3. Other cognitive outcomes: change in Attention performance [change in attention performance from baseline after 30 min (approximately)]

      Digit span forward performance assessed before baseline) and after stimulation to test for tDCS effects on attention

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Right handedness

    • unobtrusive neuropsychological screening

    Exclusion Criteria:
    • History of severe alcoholism or use of drugs.

    • Severe psychiatric disorders such as depression, psychosis (if not in remission) and severe untreated medical problems.

    • Contraindication for MRT (claustrophobia, metallic implants, ferromagnetic metals in the body, disorders of thermoregulation, pregnant women).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Charité Berlin Germany 10117

    Sponsors and Collaborators

    • Charite University, Berlin, Germany

    Investigators

    • Principal Investigator: Agnes Floeel, Prof, Charite Universitätsmedizin

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Agnes Flöel, Prof.Dr.med., Charite University, Berlin, Germany
    ClinicalTrials.gov Identifier:
    NCT03094520
    Other Study ID Numbers:
    • GEST
    First Posted:
    Mar 29, 2017
    Last Update Posted:
    May 11, 2021
    Last Verified:
    May 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of May 11, 2021